CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorder
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorder
Authors
Keywords
-
Journal
Translational Neurodegeneration
Volume 7, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-24
DOI
10.1186/s40035-018-0129-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
- (2017) Chelsea Caspell-Garcia et al. PLoS One
- Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease
- (2016) David Mengel et al. PARKINSONISM & RELATED DISORDERS
- Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson's disease: A review
- (2016) Abhishek Lenka et al. PARKINSONISM & RELATED DISORDERS
- Olfactory impairment predicts cognitive decline in early Parkinson's disease
- (2016) Michelle E. Fullard et al. PARKINSONISM & RELATED DISORDERS
- Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder
- (2016) L.M. Chahine et al. PARKINSONISM & RELATED DISORDERS
- Meta-analysis of risk factors for Parkinson’s disease dementia
- (2016) Yaqian Xu et al. Translational Neurodegeneration
- CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
- (2015) Mark Terrelonge et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- REM sleep behavior disorder and neuropathology in Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
- (2015) Daniel Weintraub et al. MOVEMENT DISORDERS
- Parkinson disease with REM sleep behavior disorder: Features, -synuclein, and inflammation
- (2015) Y. Hu et al. NEUROLOGY
- Apolipoprotein E in Alzheimer's Disease: An Update
- (2014) Jin-Tai Yu et al. Annual Review of Neuroscience
- Nonmotor Symptoms and Cognitive Decline in de novo Parkinson’s Disease
- (2014) Kyum-Yil Kwon et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson’s disease
- (2014) Yaroslau Compta et al. JOURNAL OF NEUROLOGY
- Predictors of dementia in Parkinson disease: A prospective cohort study
- (2014) J. B. M. Anang et al. NEUROLOGY
- Course of psychiatric symptoms and global cognition in early Parkinson disease
- (2014) P. de la Riva et al. NEUROLOGY
- Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG
- (2014) Kangdi Zhu et al. PARKINSONISM & RELATED DISORDERS
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
- (2013) David J. Irwin et al. NATURE REVIEWS NEUROSCIENCE
- Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study
- (2013) A. J. Yarnall et al. NEUROLOGY
- Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
- (2013) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia
- (2012) Paul T. Kotzbauer et al. ARCHIVES OF NEUROLOGY
- Genetic influences on cognitive decline in Parkinson's disease
- (2012) James F. Morley et al. MOVEMENT DISORDERS
- Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study
- (2012) Ronald B. Postuma et al. MOVEMENT DISORDERS
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
- (2012) Irene Litvan et al. MOVEMENT DISORDERS
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson’s disease patients
- (2011) Takashi Nomura et al. SLEEP MEDICINE
- Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis
- (2010) D. Aarsland et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
- (2009) Guojun Bu NATURE REVIEWS NEUROSCIENCE
- The Role of Apolipoprotein E in Alzheimer's Disease
- (2009) Jungsu Kim et al. NEURON
- Factors related to clinically probable REM sleep behavior disorder in Parkinson disease
- (2009) Ji E. Lee et al. PARKINSONISM & RELATED DISORDERS
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: A two-year follow up
- (2008) Elena Sinforiani et al. MOVEMENT DISORDERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started